Barton HA - Search Results

1

Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling.

Hoer D, Barton HA, Paini A, Bartels M, Ingle B, Domoradzki J, Fisher J, Embry M, Villanueva P, Miller D, Nguyen J, Zhang Q, Edwards SW, Tan YM. Hoer D, et al. Among authors: barton ha. Toxicol Appl Pharmacol. 2022 Apr 1;440:115922. doi: 10.1016/j.taap.2022.115922. Epub 2022 Feb 15. Toxicol Appl Pharmacol. 2022. PMID: 35176293 Free PMC article.

2

Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.

Tan YM, Barton HA, Boobis A, Brunner R, Clewell H, Cope R, Dawson J, Domoradzki J, Egeghy P, Gulati P, Ingle B, Kleinstreuer N, Lowe K, Lowit A, Mendez E, Miller D, Minucci J, Nguyen J, Paini A, Perron M, Phillips K, Qian H, Ramanarayanan T, Sewell F, Villanueva P, Wambaugh J, Embry M. Tan YM, et al. Among authors: barton ha. Regul Toxicol Pharmacol. 2021 Dec;127:105070. doi: 10.1016/j.yrtph.2021.105070. Epub 2021 Oct 28. Regul Toxicol Pharmacol. 2021. PMID: 34718074 Free PMC article.

3

Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation.

Barton HA, Chiu WA, Setzer RW, Andersen ME, Bailer AJ, Bois FY, Dewoskin RS, Hays S, Johanson G, Jones N, Loizou G, Macphail RC, Portier CJ, Spendiff M, Tan YM. Barton HA, et al. Toxicol Sci. 2007 Oct;99(2):395-402. doi: 10.1093/toxsci/kfm100. Epub 2007 May 4. Toxicol Sci. 2007. PMID: 17483121

4

Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.

Hays SM, Aylward LL, LaKind JS, Bartels MJ, Barton HA, Boogaard PJ, Brunk C, DiZio S, Dourson M, Goldstein DA, Lipscomb J, Kilpatrick ME, Krewski D, Krishnan K, Nordberg M, Okino M, Tan YM, Viau C, Yager JW; Biomonitoring Equivalents Expert Workshop. Hays SM, et al. Among authors: barton ha. Regul Toxicol Pharmacol. 2008 Aug;51(3 Suppl):S4-15. doi: 10.1016/j.yrtph.2008.05.004. Epub 2008 May 22. Regul Toxicol Pharmacol. 2008. PMID: 18583008

5

Evaluation of physiologically based pharmacokinetic models for use in risk assessment.

Chiu WA, Barton HA, DeWoskin RS, Schlosser P, Thompson CM, Sonawane B, Lipscomb JC, Krishnan K. Chiu WA, et al. Among authors: barton ha. J Appl Toxicol. 2007 May-Jun;27(3):218-37. doi: 10.1002/jat.1225. J Appl Toxicol. 2007. PMID: 17299829 Review.

6

Approaches for applications of physiologically based pharmacokinetic models in risk assessment.

Thompson CM, Sonawane B, Barton HA, DeWoskin RS, Lipscomb JC, Schlosser P, Chiu WA, Krishnan K. Thompson CM, et al. Among authors: barton ha. J Toxicol Environ Health B Crit Rev. 2008 Aug;11(7):519-47. doi: 10.1080/10937400701724337. J Toxicol Environ Health B Crit Rev. 2008. PMID: 18584453 Review.

7

Predicting age-appropriate pharmacokinetics of six volatile organic compounds in the rat utilizing physiologically based pharmacokinetic modeling.

Rodriguez CE, Mahle DA, Gearhart JM, Mattie DR, Lipscomb JC, Cook RS, Barton HA. Rodriguez CE, et al. Among authors: barton ha. Toxicol Sci. 2007 Jul;98(1):43-56. doi: 10.1093/toxsci/kfm082. Epub 2007 Apr 10. Toxicol Sci. 2007. PMID: 17426107

8

Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.

Thompson CM, Johns DO, Sonawane B, Barton HA, Hattis D, Tardif R, Krishnan K. Thompson CM, et al. Among authors: barton ha. J Toxicol Environ Health B Crit Rev. 2009 Jan;12(1):1-24. doi: 10.1080/10937400802545060. J Toxicol Environ Health B Crit Rev. 2009. PMID: 19117207 Review.

9

Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene in rat.

Barton HA, Creech JR, Godin CS, Randall GM, Seckel CS. Barton HA, et al. Toxicol Appl Pharmacol. 1995 Feb;130(2):237-47. doi: 10.1006/taap.1995.1029. Toxicol Appl Pharmacol. 1995. PMID: 7871537

10

Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment.

Clark LH, Setzer RW, Barton HA. Clark LH, et al. Among authors: barton ha. Risk Anal. 2004 Dec;24(6):1697-717. doi: 10.1111/j.0272-4332.2004.00561.x. Risk Anal. 2004. PMID: 15660623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters